Original language | English |
---|---|
Pages (from-to) | 1681-1686 |
Number of pages | 6 |
Journal | International journal of epidemiology |
Volume | 52 |
Issue number | 6 |
DOIs | |
Publication status | Published - 1 Dec 2023 |
Keywords
- Global Burden of Disease
- Institute for Health Metrics and Evaluation
- Tuberculosis
- World Health Organization
- policy
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: International journal of epidemiology, Vol. 52, No. 6, 01.12.2023, p. 1681-1686.
Research output: Contribution to journal › Review article › Academic › peer-review
TY - JOUR
T1 - Improving the quality of the Global Burden of Disease tuberculosis estimates from the Institute for Health Metrics and Evaluation
AU - Dodd, Peter J.
AU - McQuaid, Christopher Finn
AU - Rao, Prasada
AU - Abubakar, Ibrahim
AU - Arinaminpathy, Nimalan
AU - Carnegie, Anna
AU - Cobelens, Frank
AU - Dowdy, David
AU - Fiekert, Kathy
AU - Grant, Alison D.
AU - Wu, Jing
AU - Nfii, Faith Nekabari
AU - Shaikh, Nabila
AU - Houben, Rein M. G. J.
AU - White, Richard G.
N1 - Funding Information: The research was commissioned by the Global Burden of Disease Independent Advisory Committee (GBD IAC). The GBD IAC is funded by the Bill & Melinda Gates Foundation (grant reference: INV-007393). Many thanks to the IHME TB team (especially Hmwe Kyu, Amanda Novotney, Jorge Ledesma, Meixin Zhang and Lindsey Wallace) for their time and support in this process, for answering questions, discussion and generating and formatting additional data. Recommendations are from the Expert Group and do not necessarily represent the views of IHME staff. Funding Information: R.G.W. was funded by an honorarium to carry out this deep dive and is also funded for other work by the Wellcome Trust (218261/Z/19/Z), National Institutes of Health (NIH, 1R01AI147321-01, G-202303-69963), European & Developing Countries Clinical Trials Partnership (RIA208D-2505B), UK Medical Research Council (MRC, CCF17-7779 via SET Bloomsbury), Economic and Social Research Council (ES/P008011/1), Bill and Melinda Gates Foundation (BMGF, OPP1084276, OPP1135288 & INV-001754) and the World Health Organization (WHO, 2020/985800-0). P.J.D. was funded by an honorarium to carry out this deep dive and UK MRC (MR/P022081/1). F.Mc.Q. was funded by an honorarium to carry out this deep dive. N.S. was funded by an honorarium to carry out this deep dive and is currently employed by Sanofi but does not work on TB in this role. R.M.G.J.H. was funded by the European Research Council (Action Number 757699). A.D.G. received no funding for this work but is funded for work on TB by NIH (R01AI147321). The Independent Advisory Committee was set up as independent of the Global Burden of Disease, but is funded by BMGF. Acknowledgements
PY - 2023/12/1
Y1 - 2023/12/1
KW - Global Burden of Disease
KW - Institute for Health Metrics and Evaluation
KW - Tuberculosis
KW - World Health Organization
KW - policy
UR - http://www.scopus.com/inward/record.url?scp=85181176168&partnerID=8YFLogxK
U2 - https://doi.org/10.1093/ije/dyad128
DO - https://doi.org/10.1093/ije/dyad128
M3 - Review article
C2 - 37759341
SN - 0300-5771
VL - 52
SP - 1681
EP - 1686
JO - International journal of epidemiology
JF - International journal of epidemiology
IS - 6
ER -